CLINICAL_TRIALS
trial_result
· 2021-02-08
Clinical Trial Update: Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
Summary
Phase 3 clinical trial update for Efalizumab (Raptiva) in adults with moderate to severe plaque psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rockefeller University | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2021-02-08